Quarterly Consolidated Balance Sheet

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7593018

Concept As at
2022-06-30
As at
2022-03-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
59,999,000,000 JPY
61,025,000,000 JPY
Securities
13,699,000,000 JPY
13,599,000,000 JPY
Merchandise and finished goods
6,890,000,000 JPY
5,807,000,000 JPY
Work in process
2,643,000,000 JPY
2,964,000,000 JPY
Raw materials and supplies
6,189,000,000 JPY
6,209,000,000 JPY
Other
835,000,000 JPY
746,000,000 JPY
Allowance for doubtful accounts
0 JPY
JPY
Current assets
110,758,000,000 JPY
110,613,000,000 JPY
Non-current assets
Property, plant and equipment
25,296,000,000 JPY
25,734,000,000 JPY
Property, plant and equipment
Buildings and structures
Buildings and structures, net
16,926,000,000 JPY
17,142,000,000 JPY
Other
Other, net
8,370,000,000 JPY
8,591,000,000 JPY
Intangible assets
Other
970,000,000 JPY
936,000,000 JPY
Intangible assets
8,270,000,000 JPY
8,236,000,000 JPY
Investments and other assets
20,774,000,000 JPY
20,596,000,000 JPY
Investments and other assets
Investment securities
17,224,000,000 JPY
17,093,000,000 JPY
Other
3,550,000,000 JPY
3,503,000,000 JPY
Non-current assets
54,342,000,000 JPY
54,567,000,000 JPY
Assets
165,101,000,000 JPY
165,181,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
6,556,000,000 JPY
5,861,000,000 JPY
Short-term borrowings
3,850,000,000 JPY
3,850,000,000 JPY
Income taxes payable
1,322,000,000 JPY
2,436,000,000 JPY
Other
7,163,000,000 JPY
5,838,000,000 JPY
Current liabilities
19,438,000,000 JPY
19,049,000,000 JPY
Non-current liabilities
Retirement benefit liability
5,000,000,000 JPY
5,039,000,000 JPY
Other
509,000,000 JPY
431,000,000 JPY
Non-current liabilities
7,809,000,000 JPY
7,806,000,000 JPY
Liabilities
27,247,000,000 JPY
26,855,000,000 JPY
Net assets
Shareholders' equity
Share capital
23,853,000,000 JPY
23,853,000,000 JPY
Capital surplus
11,406,000,000 JPY
11,406,000,000 JPY
Retained earnings
126,416,000,000 JPY
126,347,000,000 JPY
Treasury shares
-29,360,000,000 JPY
-28,714,000,000 JPY
Shareholders' equity
132,315,000,000 JPY
132,893,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
4,642,000,000 JPY
4,551,000,000 JPY
Remeasurements of defined benefit plans
317,000,000 JPY
301,000,000 JPY
Valuation and translation adjustments
4,960,000,000 JPY
4,853,000,000 JPY
Non-controlling interests
578,000,000 JPY
578,000,000 JPY
Net assets
137,853,000,000 JPY
138,325,000,000 JPY
Liabilities and net assets
165,101,000,000 JPY
165,181,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.